FDA Recommends Against Anti Blood Clotting Drug

Posted on September 6, 2011

A negative review from the Food and Drug Administration recommends against Xarelto, an anti blood clotting drug used to prevent strokes in those with atrial fibrillation, according to news sources.

Atrial fibrillantion is a heart-rhythm disorder that increases one’s chance of a stroke. According to the staff review of the drug released by Bayer and Johnson & Johnson, there was “a lack of substantial evidence that [the drug] will have its desired effect when used as recommended. The review also did not feel the drug was proven safe, and listed bleeding as a concern.

The panel of medical experts will further review the product for long-term use in these patients and release its recommendation by November. The drug is currently approved to be used as a short-term solution for blood clots of those undergoing knee or hip-replacement surgery. The staff has considered approving the drug for second or third choice of treatment.

As a product liability lawyer, drug safety and keeping people informed of potential dangers of medical products is a big priority for me. I would like you to know that our Los Angeles personal injury lawyers are here to help you and your loved ones if anything ever does happen because of a medical product. Do not hesitate to call use right away if this medicine or any other consumer product has caused you pain and suffering and please come back to our blog regularly so that you are informed about new dangerous consumer products.

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields